References
1. Rosain J, Kong X, Martinez‐Barricarte R, Oleaga‐Quintas C,
Ramirez‐Alejo N, Markle J, et al. Mendelian susceptibility to
mycobacterial disease: 2014–2018 update. Immunol Cell Biol.
2019;97(4):360–7.
2. Das J, Banday AZ, Shandilya J, Sharma M, Vignesh P, Rawat A. An
updated review on Mendelian susceptibility to mycobacterial diseases– a
silver jubilee celebration of its first genetic diagnosis. Expert Review
of Clinical Immunology. 2021;17(10):1103–20.
3. Muriel-Vizcaino R, Yamazaki-Nakashimada M, López-Herrera G,
Santos-Argumedo L, Ramírez-Alejo N. Hemophagocytic Lymphohistiocytosis
as a Complication in Patients with MSMD. J Clin Immunol.
2016;36(5):420–2.
4. Edgar JDM, Smyth AE, Pritchard J, Lammas D, Jouanguy E, Hague R, et
al. Interferon-γ receptor deficiency mimicking Langerhans’ cell
histiocytosis. The Journal of Pediatrics. 2001;139(4):600–3.
5. de Vor IC, van der Meulen PM, Bekker V, Verhard EM, Breuning MH,
Harnisch E, et al. Deletion of the entire interferon-γ receptor 1 gene
causing complete deficiency in three related patients. J Clin Immunol.
2016;36(3):195–203.
6. Bax HI, Freeman AF, Ding L, Hsu AP, Marciano B, Kristosturyan E, et
al. Interferon Alpha Treatment of Patients with Impaired Interferon
Gamma Signaling. J Clin Immunol. 2013;33(5):991–1001.